Centessa Pharmaceuticals PLC ADR (US: CNTA) — Healthcare · Share Price, Chart & Market Data
About: Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in the United Kingdom and the United States. The company develops ORX750, an orexin receptor 2 agonist, which is in Phase IIa clinical trial for the treatment of central disorders of hypersomnolence, including narcolepsy type 1 and 2, as well as idiopathic hypersomnia. It also engages in the development of ORX142 which is in Phase I clinical trial for the treatment of neurological and neurodegenerative disorders; ORX489 which is in Phase I clinical trial for the treatment of neuropsychiatric disorders; and LockBody, an early-stage immuno-oncology program technology platform. The company was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Latest price: $39.47 (+0.10%)
CNTACentessa Pharmaceuticals PLC ADR
Loading watchlist status…
Trade CNTA now
Centessa Pharmaceuticals PLC ADR share price
CNTA price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 1:36 pm GMT+0
CNTA price performance
-0.051%
5D
37.526%
1M
66.61%
YTD
187.055%
1Y
CNTA price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 1:36 pm GMT+0
CNTA details
CNTA Market Signals